Alpha Cognition Total Liabilities 2020-2024 | ACOG
Alpha Cognition total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Alpha Cognition Annual Total Liabilities
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$4 |
| 2021 |
$4 |
| 2020 |
$8 |
| 2019 |
$1 |
Alpha Cognition Quarterly Total Liabilities
(Millions of US $) |
| 2024-06-30 |
$3 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$8 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$4 |
| 2021-12-31 |
$4 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$7 |
| 2021-03-31 |
$10 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
